We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$96.8B
AUM Growth
-$1.63B
Cap. Flow
-$6.28B
Cap. Flow %
-6.49%
Top 10 Hldgs %
7.41%
Holding
4,043
New
538
Increased
1,352
Reduced
1,501
Closed
517

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$735M
2
AAPL icon
Apple
AAPL
+$542M
3
MA icon
Mastercard
MA
+$523M
4
CRM icon
Salesforce
CRM
+$484M
5
PEP icon
PepsiCo
PEP
+$402M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 10.4%
3 Financials 10.22%
4 Healthcare 8.57%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCOM icon
2876
Fidelity MSCI Communication Services Index ETF
FCOM
$1.75B
$270K ﹤0.01%
3,811
-1,109
-23% -$75K
ZUMZ icon
2877
Zumiez
ZUMZ
$334M
$270K ﹤0.01%
+13,792
New +$228K
CEPT
2878
DELISTED
Cantor Equity Partners II
CEPT
$269K ﹤0.01%
25,456
+292
+1% +$3.14K
OTF
2879
Blue Owl Technology Finance Corp
OTF
$4.57B
$268K ﹤0.01%
+19,414
New +$291K
NRC icon
2880
NRC Health Common Stock
NRC
$419M
$266K ﹤0.01%
20,798
-9,260
-31% -$139K
RBA icon
2881
RB Global
RBA
$20.5B
$260K ﹤0.01%
2,400
-9,450
-80% -$1.06M
TWIN icon
2882
Twin Disc
TWIN
$329M
$260K ﹤0.01%
18,630
+2,696
+17% +$29.2K
IWR icon
2883
iShares Russell Mid-Cap ETF
IWR
$56.1B
$259K ﹤0.01%
2,682
-6,571
-71% -$623K
GALT icon
2884
Galectin Therapeutics
GALT
$213M
$258K ﹤0.01%
60,867
+45,297
+291% +$170K
CCCC icon
2885
C4 Therapeutics
CCCC
$405M
$257K ﹤0.01%
+115,973
New +$278K
AFL icon
2886
CALL
Aflac
AFL
$64.8B
$257K ﹤0.01%
2,300
+1,800
+360% +$189K
DFUS
2887
Dimensional US Equity ETF
DFUS
$20.7B
$255K ﹤0.01%
3,526
+3,073
+678% +$214K
CVBF icon
2888
CVB Financial
CVBF
$4B
$254K ﹤0.01%
+13,409
New +$267K
ESEA icon
2889
Euroseas
ESEA
$560M
$253K ﹤0.01%
+4,250
New +$239K
ONL
2890
Orion Office REIT
ONL
$148M
$252K ﹤0.01%
93,509
+64,582
+223% +$173K
BTI icon
2891
CALL
British American Tobacco
BTI
$133B
$249K ﹤0.01%
+4,700
New +$255K
MCHI icon
2892
iShares MSCI China ETF
MCHI
$6.28B
$249K ﹤0.01%
3,782
-70,435
-95% -$4.22M
XLG icon
2893
Invesco S&P 500 Top 50 ETF
XLG
$10.5B
$249K ﹤0.01%
4,326
-5,303
-55% -$290K
UDOW icon
2894
ProShares UltraPro Dow 30
UDOW
$829M
$249K ﹤0.01%
+4,646
New +$231K
VTEB icon
2895
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
$248K ﹤0.01%
4,958
-15,456
-76% -$760K
TWO
2896
Two Harbors Investment
TWO
$1.27B
$244K ﹤0.01%
24,743
-148,041
-86% -$1.49M
VOX icon
2897
Vanguard Communication Services ETF
VOX
$5.52B
$244K ﹤0.01%
1,299
+460
+55% +$82.1K
UDMY
2898
DELISTED
Udemy
UDMY
$241K ﹤0.01%
+34,331
New +$241K
XLY icon
2899
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
$240K ﹤0.01%
2,000
-400
-17% -$45.8K
FUNC icon
2900
First United
FUNC
$283M
$239K ﹤0.01%
+6,503
New +$229K

Similar funds

Qube Research & Technologies (QRT)'s Q3 2025 Portfolio in Review

As of Q3 2025, Qube Research & Technologies (QRT) held 4,043 positions worth $96.8B, down 1.7% from $98.4B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Qube Research & Technologies (QRT) withdrew a net $6.28B in Q3 2025, closing 517 positions and reducing 1,501 holdings. Its most notable exit was Applovin, an estimated $390M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

Against the trend, Qube Research & Technologies (QRT) opened a new position in Broadcom worth $754M.

  • Qube Research & Technologies (QRT)'s largest Q3 2025 buy was Broadcom: 2,284,316 shares worth $754M.
  • Qube Research & Technologies (QRT) added most to Microsoft in Q3 2025, an estimated $775M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2025 reduction was Thermo Fisher Scientific, cutting an estimated $735M.
  • Qube Research & Technologies (QRT) fully exited Applovin in Q3 2025, selling an estimated $390M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.4% of its $96.8B portfolio in Q3 2025.
  • Qube Research & Technologies (QRT) opened 538 new positions and closed 517 in Q3 2025.
  • Qube Research & Technologies (QRT)'s portfolio value fell 1.7% quarter-over-quarter to $96.8B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.